Pipeline Watch: Phase III Results With Tagrisso, Biosimilar Rituximab And Vonvendi

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.